Dirk Koschel

Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu, Martine Rémy‐Jardin, Christopher J. Ryerson et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 1K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry

Jürgen Behr, Michael Kreuter, Marius M. Hoeper et al. · European Respiratory Journal · 2015 · 244 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis

Michael Kreuter, Wim Wuyts, Elisabetta Renzoni et al. · The Lancet Respiratory Medicine · 2016 · 219 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16